Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-01-21

FDA Approved: MIOSTAT — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MIOSTAT (carbachol) from Alcon Laboratories, Inc., updating the labeling for its ocular use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIOSTAT (carbachol)

Snippet

SUPPL AP for MIOSTAT (CARBACHOL)